Financing ·
On June 18, 2026, stockholders approved two proposals under Nasdaq Rule 5635 to authorize the issuance of common stock…
TPSTTempest Therapeutics, Inc.
On June 18, 2026, stockholders approved two proposals under Nasdaq Rule 5635 to authorize the issuance of common stock upon warrant exercise. The first proposal authorizes up to 925,927 shares for Series A Warrants and 925,927 shares for Series B Warrants issued March 20, 2026. The second proposal authorizes up to 2,344,828 shares for Common Warrants issued in connection with a May 28, 2026, inducement offer. Tempest Therapeutics, Inc. is a biotechnology company that develops therapeutic treatments.